We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
For investors seeking momentum, iShares U.S. Healthcare ETF (IYH - Free Report) is probably on the radar. The fund just hit a 52-week high and has risen 23.24% from its 52-week low of $53.35 per share.
But, are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook to get a better idea of where it might head:
IYH in Focus
The underlying Russell 1000 Health Care RIC 22.5/45 Capped Gross Index measures the performance of the healthcare sector of the U.S. equity market. The product charges 38 bps in annual fees (See: All Health Care ETFs).
Why the Move?
Healthcare has picked up momentum lately, with investors seeking safety amid growing worries about AI overvaluation. The fund has allocated about 14.60% to Eli Lilly (LLY - Free Report) , which briefly surpassed the $1 trillion market cap mark on Nov. 21, making it the first healthcare company to break into a club long ruled by tech heavyweights.
Additionally, the increasing adoption of AI in U.S. healthcare continues to provide a meaningful tailwind for the sector.
More Gains Ahead?
Currently, IYH has a Zacks ETF Rank #3 (Hold) with a High risk outlook. However, it might continue its strong performance in the near term, with a positive weighted alpha of 11.59 (as per Barchart.com), which gives cues of a further rally.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Healthcare ETF (IYH) Hits New 52-Week High
For investors seeking momentum, iShares U.S. Healthcare ETF (IYH - Free Report) is probably on the radar. The fund just hit a 52-week high and has risen 23.24% from its 52-week low of $53.35 per share.
But, are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook to get a better idea of where it might head:
IYH in Focus
The underlying Russell 1000 Health Care RIC 22.5/45 Capped Gross Index measures the performance of the healthcare sector of the U.S. equity market. The product charges 38 bps in annual fees (See: All Health Care ETFs).
Why the Move?
Healthcare has picked up momentum lately, with investors seeking safety amid growing worries about AI overvaluation. The fund has allocated about 14.60% to Eli Lilly (LLY - Free Report) , which briefly surpassed the $1 trillion market cap mark on Nov. 21, making it the first healthcare company to break into a club long ruled by tech heavyweights.
Additionally, the increasing adoption of AI in U.S. healthcare continues to provide a meaningful tailwind for the sector.
More Gains Ahead?
Currently, IYH has a Zacks ETF Rank #3 (Hold) with a High risk outlook. However, it might continue its strong performance in the near term, with a positive weighted alpha of 11.59 (as per Barchart.com), which gives cues of a further rally.